Stock ScreenerStock IdeasStrong Buys According to Wall Street
Strong Buys According to Wall Street
Companies with high upside and a consensus strong buy recommendation from Wall Street analysts

Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
Ticker
Company
Market Cap
Dividend Yield
Payout Ratio
Last Dividend
Annual Dividend
Dividend Percentile
Dividend Dropped Count (L10Y)
Ex-dividend Date
Div. Payment Date
BDTX
BLACK DIAMOND THERAPEUTICS INC
$136.17MN/A0.00%N/AN/AN/AN/A
HTFL
HEARTFLOW INC
$2.40BN/AN/AN/AN/AN/AN/A
FBRX
FORTE BIOSCIENCES INC
$401.36MN/A0.00%N/AN/AN/AN/A
W
WAYFAIR INC
$11.85BN/A0.00%N/AN/AN/AN/A
NBP
NOVABRIDGE BIOSCIENCES
$394.49MN/A0.00%N/AN/AN/AN/A
CNTX
CONTEXT THERAPEUTICS INC
$211.32MN/A0.00%N/AN/AN/AN/A
LAKE
LAKELAND INDUSTRIES INC
$93.84M0.94%-2.70%$0.0300$0.0922%0
SYRE
SPYRE THERAPEUTICS INC
$2.49BN/A0.00%N/AN/AN/AN/A
BETA
BETA TECHNOLOGIES INC
$4.13BN/AN/AN/AN/AN/AN/A
ZYME
ZYMEWORKS INC
$1.73BN/A0.00%N/AN/AN/AN/A
CSTL
CASTLE BIOSCIENCES INC
$1.02BN/A0.00%N/AN/AN/AN/A
LBRX
LB PHARMACEUTICALS INC
$535.58MN/AN/AN/AN/AN/AN/A
CEVA
CEVA INC
$496.45MN/A0.00%N/AN/AN/AN/A
ZGN
ERMENEGILDO ZEGNA NV
$2.47BN/AN/A$0.0900N/AN/A0
MARA
MARA HOLDINGS INC
$3.13BN/A0.00%N/AN/AN/AN/A
KRRO
KORRO BIO INC
$115.46MN/A0.00%N/AN/AN/AN/A
ABVX
ABIVAX SA
$8.28BN/AN/AN/AN/AN/AN/A
AKA
AKA BRANDS HOLDING CORP
$117.71MN/A0.00%N/AN/AN/AN/A
CHYM
CHIME FINANCIAL INC
$8.14BN/AN/AN/AN/AN/AN/A
TYRA
TYRA BIOSCIENCES INC
$1.64BN/A0.00%N/AN/AN/AN/A
CARL
CARLSMED INC
$306.08MN/AN/AN/AN/AN/AN/A
CLFD
CLEARFIELD INC
$421.68MN/A0.00%N/AN/AN/AN/A
NEXN
NEXXEN INTERNATIONAL LTD
$175.82MN/A0.00%N/AN/AN/AN/A
IMTX
IMMATICS NV
$1.14BN/A0.00%N/AN/AN/AN/A
CGTX
COGNITION THERAPEUTICS INC
$90.92MN/A0.00%N/AN/AN/AN/A
CRVO
CERVOMED INC
$43.21MN/A0.00%N/AN/AN/AN/A
KYMR
KYMERA THERAPEUTICS INC
$5.59BN/A0.00%N/AN/AN/AN/A
SLDB
SOLID BIOSCIENCES INC
$507.97MN/A0.00%N/AN/AN/AN/A
TERN
TERNS PHARMACEUTICALS INC
$3.25BN/A0.00%N/AN/AN/AN/A
PCVX
VAXCYTE INC
$7.24BN/A0.00%N/AN/AN/AN/A
CGEM
CULLINAN THERAPEUTICS INC
$728.41MN/A0.00%N/AN/AN/AN/A
GHI
GREYSTONE HOUSING IMPACT INVESTORS LP
$182.29M15.78%788.20%$0.2500$1.2298%7
GHRS
GH RESEARCH PLC
$963.94MN/A0.00%N/AN/AN/AN/A
OLMA
OLEMA PHARMACEUTICALS INC
$1.81BN/A0.00%N/AN/AN/AN/A
HELP
CYBIN INC
$146.49MN/A0.00%N/AN/AN/AN/A
SGMT
SAGIMET BIOSCIENCES INC
$197.73MN/A0.00%N/AN/AN/AN/A
NTSK
NETSKOPE INC
$5.16BN/AN/AN/AN/AN/AN/A
USAR
USA RARE EARTH INC
$3.12BN/A0.00%N/AN/AN/AN/A
MBX
MBX BIOSCIENCES INC
$1.72BN/A0.00%N/AN/AN/AN/A
LUCK
LUCKY STRIKE ENTERTAINMENT CORP
$1.01B3.07%-33.60%$0.0600$0.2364%0
GLUE
MONTE ROSA THERAPEUTICS INC
$1.27BN/A0.00%N/AN/AN/AN/A
CRVS
CORVUS PHARMACEUTICALS INC
$1.55BN/A0.00%N/AN/AN/AN/A
BNTX
BIONTECH SE
$26.15BN/A0.00%$2.1110N/AN/A0
LXEO
LEXEO THERAPEUTICS INC
$530.62MN/A0.00%N/AN/AN/AN/A
VOYG
VOYAGER TECHNOLOGIES INC
$1.65BN/AN/AN/AN/AN/AN/A
OKLO
OKLO INC
$10.66BN/A0.00%N/AN/AN/AN/A
HOWL
WEREWOLF THERAPEUTICS INC
$31.16MN/A0.00%N/AN/AN/AN/A
ORIC
ORIC PHARMACEUTICALS INC
$1.03BN/A0.00%N/AN/AN/AN/A
UPB
UPSTREAM BIO INC
$1.59BN/A0.00%N/AN/AN/AN/A
KYTX
KYVERNA THERAPEUTICS INC
$333.73MN/A0.00%N/AN/AN/AN/A
ACRV
ACRIVON THERAPEUTICS INC
$53.33MN/A0.00%N/AN/AN/AN/A
RAPP
RAPPORT THERAPEUTICS INC
$1.26BN/A0.00%N/AN/AN/AN/A
CBIO
CRESCENT BIOPHARMA INC
$134.90MN/A0.00%N/AN/AN/AN/A
APGE
APOGEE THERAPEUTICS INC
$4.43BN/A0.00%N/AN/AN/AN/A
IDYA
IDEAYA BIOSCIENCES INC
$2.92BN/A0.00%N/AN/AN/AN/A
NRIX
NURIX THERAPEUTICS INC
$1.70BN/A0.00%N/AN/AN/AN/A
NAVN
NAVAN INC
$2.75BN/AN/AN/AN/AN/AN/A
PEPG
PEPGEN INC
$337.55MN/A0.00%N/AN/AN/AN/A
AIRG
AIRGAIN INC
$55.96MN/A0.00%N/AN/AN/AN/A
ANRO
ALTO NEUROSCIENCE INC
$466.00MN/A0.00%N/AN/AN/AN/A
TRVI
TREVI THERAPEUTICS INC
$1.47BN/A0.00%N/AN/AN/AN/A
CYRX
CRYOPORT INC
$465.64MN/A0.00%N/AN/AN/AN/A
IMRX
IMMUNEERING CORP
$306.06MN/A0.00%N/AN/AN/AN/A
CTMX
CYTOMX THERAPEUTICS INC
$960.70MN/A0.00%N/AN/AN/AN/A
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.